Scientific publications

Frontiers in Immunology, 2025
Case Report: Serum sickness induced by dupilumab—clinical insights and Olinkproteomic analysis

Zhu H., Huang Q., Zheng L. et al.

Liver Cancer, 2025
Camrelizumab combined with Lenvatinib and RALOX-HAIC for unresectable hepatocellular carcinoma (Cal Era): a prospective, single-arm, phase II trial

Zang M., Li Q., Hu X. et al.

Nature Medicine, 2025
A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial

Xu Z., Ren F., Wang P. et al.

Discover Oncology, 2025
Exploring the causal relationship between immune factors and chondrosarcoma: a Mendelian randomization study

Xu T., Xiao W., Li W. et al.

Signal Transduction and Targeted Therapy, 2025
Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study

Xie M., Bao M., Dong X. et al.

Frontiers in Immunology, 2025
Baseline profile peripheral Tfh cells predict immune-related adverse events in immune checkpoint inhibitor therapy of gastrointestinal cancer

Wang Y., Zhang Z., Xie T. et al.

European Neuropsychopharmacology, 2025
Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis

Oliva V., Possidente C., Fanelli G. et al.

Aging Cell, 2025
Quercetin Reduces Vascular Senescence and Inflammation in Symptomatic Male but Not Female Coronary Artery Disease Patients

Mury P., Dagher O., Fortier A. et al.

Nature Communications, 2025
In depth transcriptomic profiling defines a landscape of dysfunctional immune responses in patients with VEXAS syndrome

Mizumaki H., Gao S., Wu Z. et al.

Blood Journal, 2025
Ruxolitinib Targets JAK-STAT Signaling to Modulate Neutrophil Activation in Refractory Macrophage Activation Syndrome

Ma Y., Chen X., Wang M. et al.

Journal of the American Heart Association, 2025
IL1RAP Expression in Human Atherosclerosis: A Target of Novel Antibodies to Reduce Vascular Inflammation and Adhesion

Lindkvist M., Göthlin Eremo A., Paramel G. et al.

Postgraduate Medical Journal, 2025
Uncovering novel metabolic and inflammatory pathways in gout using Mendelian randomization

Li Q., Guo R., Wu Z. et al.

Med, 2025
Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis uncovers pathways associated with mortality

Le T., van Abeelen K., Ardiansyah E. et al.

Proceedings of the National Academy of Sciences, 2025
A proteomic signature of healthspan

Kuo C., Liu P., Drouard G. et al.

Medicina, 2025
Long COVID and Biomarker Dysregulation—A Shift Toward Immune Exhaustion?

Kallaste A., Kisand K., Aart A. et al.

Allergy, 2025
Deciphering the Connection Between Atopic Dermatitis and Cardiovascular Diseases: Analysis of Clinical Associations and Cardiometabolic Proteins

Fehr D., Huynh‐Tran V., Maintz L. et al.

The American Journal of Clinical Nutrition, 2025
Relationship of healthy lifestyle with healthy aging and the mediation by plasma proteins: a prospective cohort study

Fang F., Liu Z., Lyu J. et al.

Journal of Interferon & Cytokine Research, 2025
Significant Associations Between Blood Cell Counts and a Large Number of Salivary Cytokines, Chemokines, and Growth Factors

Eriksson L., Eriksson M., Gordh T. et al.

Medicine, 2025
Roles of plasma proteins in mediating the causal effect of the lipid species on gastric cancer: Insights from proteomic and two-step Mendelian randomization

Dong Z., Chen Z., Yu K. et al.

Brain and Behavior, 2025
Causal Relationships Between the Gut Microbiota, Inflammatory Cytokines, and Amyotrophic Lateral Sclerosis: A Mendelian Randomization Analysis

Changqing L., Leying Y., Caiyun M. et al.